Authors: Dr. Barry Sears

The Mediterranean Zone (37 page)

BOOK: The Mediterranean Zone

10.62Mb size Format: txt, pdf, ePub

ads

Greene ER, Huang S, Serhan CN, and Panigrahy D. “Regulation of inflammation in cancer by eicosanoids.” Prostaglandins and Other Lipid Mediators 96: 27–36 (2011)

Holvoet P. “Oxidized LDL and coronary heart disease.” Acta Cardiol 59: 479–484 (2004)

Hotamisligil GS, Arner P, Caro JF, Atkinson RL, and Spiegelman BM. “Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.” J Clin Invest 95: 2409–2415 (1995)

Ishigaki Y, Oka Y, and Katagiri H. “Circulating oxidized LDL: a biomarker and a pathogenic factor.” Curr Opin Lipidol 20: 363–369 (2009)

Jornayvaz FR, Jurczak MJ, Lee HY, Birkenfeld AL, Frederick DW, Zhang D, Zhang XM, Samuel VT, and Shulman GI. “A high-fat, ketogenic diet causes hepatic insulin
resistance in mice, despite increasing energy expenditure and preventing weight gain.” Am J Physiol Endocrinol Metab 299: E808–15 (2010)

Joslin Diabetes Reseach Center.
www.joslin.org/docs/Nutrition_Guideline_Graded.pdfEPIC
and Diabetes (2007)

Kratsovnik E, Bromberg Y, Sperling O, and Zoref-Shani E. “Oxidative stress activates transcription factor NF-kB-mediated protective signaling in primary rat neuronal cultures.” J Mol Neurosci 26: 27–32 (2005)

Krishnamoorthy S and Honn KV. “Eicosanoids in tumor progression and metastasis.” Subcell Biochem 49: 145–168 (2008)

Leaf C. The Truth in Small Doses: Why We’re Losing the War on Cancer- and How to Win It. Simon and Shuster. New York, NY (2013)

Li N and Karin M. “Is NF-kappaB the sensor of oxidative stress?” FASEB J 13: 1137–1143 (1999)

Maruyama C, Imamura K, and Teramoto T. “Assessment of LDL particle size by triglyceride/HDL-cholesterol ratio in non-diabetic, healthy subjects without prominent hyperlipidemia.” J Atheroscler Thromb 10: 186–91 (2003)

McLaughlin T, Reaven G, Abbasi F, Lamendola C, Saad M, Waters D, Simon J, and Krauss RM. “Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?” Am J Cardiol 96: 399–404 (2005)

Meisinger C, Baumert J, Khuseyinova N, Lowel H, and Koenig W. “Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population.” Circulation 112: 651–657 (2005)

Miller BS and Yee D. “Type I insulin-like growth factor receptor as a therapeutic target in cancer.” Cancer Res 65: 10123–10137 (2005)

Nazaryan A. “Getting Cancer Wrong.” Newsweek. March 20, 2014 (2014)

Nielsen MS, Gronholdt M-L, Vyberg M, Overvad K, Andreasen A, Due K-M, and Schmidt EB. “Adipose tissue arachidonic acid content is associated with expression of 5-lipoxygenase in atherosclerotic plaques.” Lipids in Health and Dis 12: 7 (2013)

Pelikanova T, Kohout M, Base J, Stefka Z, Kovar J, Kazdova L, and Valek J. “Effect of acute hyperinsulinemia on fatty acid composition of serum lipids in non-insulin-dependent diabetics and healthy men.” Clin Chim Acta 203: 329–337 (1991)

Rahman I, Gilmour PS, Jimenez LA, and MacNee W. “Oxidative stress and TNF-alpha induce histone acetylation and NF-kappaB/AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation.” Mol Cell Biochem 235: 239–248 (2002)

Rhee JW, Lee KW, Kim D, Lee Y, Jeon OH, Kwon HJ, and Kim DS. “NF-kappaB-dependent regulation of matrix metalloproteinase-9 gene expression by lipopolysaccharide in a macrophage cell line RAW 264.7.” J Biochem Mol Biol 40: 88–94 (2007)

Sears B.
The Anti-inflammation Zone
. Regan Books. New York, NY (2005)

Sears B.
Toxic Fat
. Thomas Nelson. Nashville, TN (2008)

Tabues G. “Prosperity’s Plague.” Science 325: 256–260 (2009)

Terrando N, Gomez-Galan M, Yang T, Carlstrom M, Gustavsson D, Harding RE, Lindskog M, and Eriksson LI. “Asprin-triggered resolvin D1 prevent surgery-induced cognitive decline.” FASEB J 27: 3564–3571 (2013)

Thies F, Garry JM, Yaqoob P, Rerkasem K, Williams J, Shearman CP, Gallagher PJ, Calder PC, and Grimble RF. “Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial.” Lancet. 361: 477–485 (2003)

Wassink AM, Van Der Graaf Y, Soedamah-Muthu SS, Spiering W, and Visseren FL. “Metabolic syndrome and incidence of type 2 diabetes in patients with manifest vascular disease.” Diab Vasc Dis Res 5: 114–122 (2008)

Wierzbicki AS, Purdon SD, Hardman TC, Kulasegaram R, and Peters BS. “HIV lipodystrophy and its metabolic consequences: implications for clinical practice.” Curr Med Res Opin 24: 609–624 (2008)

Williams ES, Baylin A, and Campos H. “Adipose tissue arachidonic acid and the metabolic syndrome in Costa Rican adults.” Clin Nutr 26: 474–482 (2007)

Zhang X, Zhang G, Zhang H, Karin M, Bai H, and Cai D. “Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity.” Cell 135: 61–73 (2008)

APPENDIX E. INFLAMMATION AND AGING

Ambati J, Atkinson JP, and Gelfand BD. “Immunology of age-related macular degeneration.” Nat Rev Immunol 13: 438–451 (2013)

Bjorntorp P. “Hormonal control of regional fat distribution.” Hum Reprod 12 Suppl 1: 21–25 (1997)

Borg M, Brincat S, Camilleri G, Schembri-Wismayer P, Brincat M, and Calleja-Agius J. “The role of cytokines in skin aging.” Climacteric 16: 514–521 (2013)

Casado-Díaz A, Santiago-Mora R, Dorado G, and Quesada-Gómez JM. “The omega-6 arachidonic fatty acid, but not the omega-3 fatty acids, inhibits osteoblastogenesis and induces adipogenesis of human mesenchymal stem cells: potential implication in osteoporosis.” Osteoporos Int 24: 1647–1661 (2013)

Gao L, Faibish D, Fredman G, Herrera BS, Chiang N, Serhan CN, Van Dyke TE, and Gyurko R. “Resolvin E1 and chemokine-like receptor 1 mediate bone preservation.” J Immunol 190: 689–694 (2013)

Garza LA, Liu Y, Yang Z, Alagesan B, Lawson JA, Norberg SM, Loy DE, Zhao T, Blatt HB, Stanton DC, Carrasco L, Ahluwalia G, Fischer SM, FitzGerald GA, and Cotsarelis G. “Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia.” Sci Transl Med. 4: 126ra34 (2012)

Georgiou T, Neokleous A, Nikolaou D, and Sears B. “Pilot study for treating dry age-related macular degeneration (AMD) with high-dose omega-3 fatty acids.” PharmaNutrition 2: 8–11 (2014)

Guertin DA and Sabatini DM. “Defining the role of mTOR in cancer.” Cancer Cell 12: 9–22 (2007)

Jenkins G. “Molecular mechanisms of skin ageing.” Mech Ageing Dev 123: 801–810 (2002)

Li F, Yin Y, Tan B, Kong X, and Wu G. “Leucine nutrition in animals and humans: mTOR signaling and beyond.” Amino Acids 41: 1185–1193 (2011)

Nieves A and Garza LA. “Does prostaglandin D2 hold the cure to male pattern baldness?” Exp Dermatol. 23: 224–227 (2014)

Norton LE, Wilson GJ, Layman DK, Moulton CJ, and Garlick PJ. “Leucine content of dietary proteins is a determinant of postprandial skeletal muscle protein synthesis in adult rats.” Nutr Metab 20: 67 (2012)

Rahman I, Biswas SK, and Kirkham PA. “Regulation of inflammation and redox signaling by dietary polyphenols.” Biochem Pharmacol 72: 1439–1452 (2006)

Scapagnini G, Vasto S, Abraham NG, Caruso C, Zella D, and Fabio G. “Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders.” Mol Neurobiol 44: 192–201 (2011)

Sears, B.
The Anti-Aging Zone
. Regan Books. New York, NY (1999)

Shi Y, Luo LF, Liu XM, Zhou Q, Xu SZ, and Lei TC. “Premature graying as a consequence of compromised antioxidant activity in hair bulb melanocytes and their precursors.” PLoS One9: e93589 (2014)

Shinto L, Marracci G, Baldauf-Wagner S, Strehlow A, Yadav V, Stuber L, and Bourdette D. “Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis.” Prostaglandins Leukot Essent Fatty Acids 80: 131–136 (2009)

Tanaka K, Asamitsu K, Uranishi H, Iddamalgoda A, Ito K, Kojima H, and Okamoto T. “Protecting skin photoaging by NF-kappaB inhibitor.” Curr Drug Metab11: 431–435 (2010)

Wang F, Mullican SE, DiSpirito JR, Peed LC, and Lazar MA. “Lipoatrophy and severe metabolic disturbance in mice with fat-specific deletion of PPARγ.” Proc Natl Acad Sci U S A110: 18656–18661 (2013)

APPENDIX F. MARKERS OF WELLNESS

Bierhaus A, Stern DM, and Nawroth PP. “RAGE in inflammation: a new therapeutic target?” Curr Opin Investig Drugs 7: 985–991 (2006)

Carson AP, Fox CS, McGuire DK, Levitan EB, Laclaustra M, Mann DM, and Muntner P. “Low hemoglobin A1c and risk of all-cause mortality among US adults without diabetes.” Circ Cardiovasc Qual Outcomes 3: 661–667 (2010)

Campbell B, Badrick T, Flatman R, and Kanowshi D. “Limited clinical utility of high-sensitivity plasma C-reactive protein assays.” Ann Clin Biochem39: 85–88 (2002)

Campbell B, Flatman R, Badrick T, and Kanowshi D. “Problems with high-sensitivity C-reactive protein.” Clin Chem 49: 201 (2003)

Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JW, Cannon JG, Rogers TS, Klempner MS, Weber PC, Schafter EJ, Wolff SM, and Dinarello CA. “The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells.” N Engl J Med 320: 265–271 (1989)

Harris WS, Pottala JV, Varvel SA, Borowski JJ, Ward JN, and McConnell JP. “Erythrocyte omega-3 fatty acids increase and linoleic acid decreases with age: observations from 160,000 patients.” Prostaglandins Leukot Essent Fatty Acids. 88: 257–263 (2013)

Mozaffarian D, Lemaitre RN, King IB, Song X, Huang H, Sacks FM, Rimm EB, Wang M,
and Siscovick DS. “Plasma phospholipid long-chain ω-3 fatty acids and total and cause-specific mortality in older adults: a cohort study.” Ann Intern Med. 158: 515–525 (2013)

Murguia-Romero M, Jimenez-Flores JR, Sigrist-Flores SC, Espinoza-Camacho MA, Jimenez-Morales M, Pina E, Mendez-Cruz AR, Villalobos-Molina R, and Reaven GM. “Plasma triglyceride/HDL-cholesterol ratio, insulin resistance, and cardiometabolic risk in young adults.” J Lipid Res 54: 2795–2799 (2013)

Ramasamy R, Vannucci SJ, Yan SS, Herold K, Yan SF, and Schmidt AM. “Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation.” Glycobiology 15: 16R–28R (2005)

Sears, B.
The OmegaRx Zone
. Regan Books. New York, NY (2002)

Tall AR. “C-reactive protein reassessed.” N Engl J Med 350: 1450–1452 (2004)

APPENDIX G. POLYPHENOLS AND ORAC VALUES

Perez-Jimenez J, Neveu V, Vos F, and Scalbert A. “Identification of the 100 richest dietary sources of polyphenols.” Eur J Clin Nutr 64: S112–S120 (2010)

Prior RL, Cao G, Prior RL, and Cao G. “Analysis of botanicals and dietary supplements for antioxidant capacity: a review.” J AOAC Int 83: 950–956 (2000)

ABOUT THE AUTHOR

B
ARRY
S
EARS
, P
H
.D., is recognized as one of the world’s leading medical researchers on the hormonal effects of food. He is the #1
New York Times
bestsellering author of thirteen books, including
The Zone, Mastering the Zone,
and
Zone-Perfect Meals in Minutes
. His books have sold more than six million copies and have been translated into twenty-two languages. Dr. Sears has been a frequent guest on many national programs, including
20/20
,
Today, Good Morning America,
and
CBS Morning News
. A former research scientist at the Boston University School of Medicine and the Massachusetts Institute of Technology, he continues his research on the inflammatory process as the president of the nonprofit Inflammation Research Foundation in Marblehead, Massachusetts. The father of two grown daughters, he lives in Swampscott, Massachusetts, with his wife, Lynn.